These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1232532)

  • 1. Non-Hodgkin's lymphoma in children.
    Wollner N; Burchenal JH; Lieberman PH; Exelby PR; D'Angio GJ; Murphy ML
    Med Pediatr Oncol; 1975; 1(3):235-63. PubMed ID: 1232532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
    Sullivan MP; Boyett J; Pullen J; Crist W; Doering EJ; Trueworthy R; Hvizdala E; Ruymann F; Steuber CP
    Cancer; 1985 Jan; 55(2):323-36. PubMed ID: 3880656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy.
    Wollner N; Burchenal JH; Lieberman PH; Exelby P; D'Angio G; Murphy ML
    Cancer; 1976 Jan; 37(1):123-34. PubMed ID: 1247950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Hodgkin's lymphoma in children: results of treatment with LSA2-L2 protocol.
    Wollner N; Lieberman P; Exelby P; D'angio G; Burchenal J; Fang S; Murphy ML
    Br J Cancer Suppl; 1975 Mar; 2():337-42. PubMed ID: 1058708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J; Filippa DA; Qin J; Wollner N
    Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
    Durant JR; Gams RA; Bartolucci AA; Dorfman RF
    Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the LSA2L2 protocol for treatment of childhood non-Hodgkin's lymphoma. A report from the Polish Children's Leukemia/Lymphoma Study Group.
    Bogusławska-Jaworska J; Kościelniak E; Sroczyńska M; Sońta-Jakimczyk D; Armata J; Balwierz W; Ciepielewska D; Kaczmarek-Kanold M; Ochocka M; Radwańska U
    Am J Pediatr Hematol Oncol; 1984; 6(4):363-70. PubMed ID: 6549496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LSA2-L2 protocol treatment of stage IV non-Hodgkin's lymphoma in children with partial and extensive bone marrow involvement.
    Duque-Hammershaimb L; Wollner N; Miller DR
    Cancer; 1983 Jul; 52(1):39-43. PubMed ID: 6573941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic changes in juvenile abdominal non-Hodgkin's lympomas (NHL)].
    Sigg C; Plüss HJ; Hitzig WH
    Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1056-9. PubMed ID: 7423149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoblastic lymphoma in children--a randomized trial comparing LSA2-L2 with the A-COP+ therapeutic regimen: a Pediatric Oncology Group Study.
    Hvizdala EV; Berard C; Callihan T; Falletta J; Sabio H; Shuster JJ; Sullivan M; Wharam MD
    J Clin Oncol; 1988 Jan; 6(1):26-33. PubMed ID: 3275750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy in malignant diseases.
    Fairley GH
    J R Coll Physicians Lond; 1971 Jan; 5(2):167-77. PubMed ID: 4950464
    [No Abstract]   [Full Text] [Related]  

  • 12. [High risk acute lymphoblastic leukaemia in children. Preliminary report after introducing a new version of New York (1997) protocol adjusted to the age of the patients. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].
    Skoczen S; Klus K; Armata J; Kowalczyk J; Wisniewska-Slusarz H; Kolecki P; Derwich K; Matysiak M; Krauze A; Rokicka-Milewska R; Pawelec K; Boguslawska-Jaworska J; Juszczak K; Pisarek J; Sońta-Jakimczyk D; Tomaszewska R; Łuszczynska A; Wysocki M; Styczyński J
    Med Wieku Rozwoj; 2000; 4(1 Suppl 2):23-32. PubMed ID: 12021459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of acute lymphoblastic leukemia in children.
    Haghbin M
    Am J Hematol; 1976; 1(2):201-9. PubMed ID: 1069475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of LSA2-L2 therapy in 26 children with non-Hodgkin's lymphoma.
    Pichler E; Jürgenssen OA; Radaszkiewicz T; Reinartz G; Mutz I; Urban C; Krepler P; Schmidmeier W; Becker H; Kundi M
    Cancer; 1982 Dec; 50(12):2740-6. PubMed ID: 6897203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood cancer: the improving prognosis.
    Sutow WW; Sullivan MP
    Postgrad Med; 1976 Feb; 59(2):131-7. PubMed ID: 175358
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Hodgkin's lymphoma in children; diffuse lymphoblastic histology; diffuse non-lymphoblastic histology; LSA2-L2 experience.
    Wollner N
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():122-6. PubMed ID: 3214018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases].
    Sun XF; Jiang WQ; Liu DG; Xia ZJ; Huang HQ; Zhang L; Li YH; Zhou ZM; Zhen ZJ; Xia Y; He YJ; Guan ZZ
    Ai Zheng; 2004 Dec; 23(12):1687-91. PubMed ID: 15601561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2).
    Anderson JR; Wilson JF; Jenkin DT; Meadows AT; Kersey J; Chilcote RR; Coccia P; Exelby P; Kushner J; Siegel S; Hammond D
    N Engl J Med; 1983 Mar; 308(10):559-65. PubMed ID: 6338381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.